This heightened MMP9 presence, driven by chemotherapy, not only poses a risk for the development of CIPN but also risks exacerbating cancer outcomes by facilitating tumor invasion and metastasis through its remodeling capabilities (Florin Georgescu et al., 2015; Mudatsir et al., 2023). Here, MMP9 is linked to cancer.